A/Prof Ingrid Hopper

Update for GPs "Treating comorbidities in heart failure: tackling the hidden burden". bit.ly/4o9AMyg The Medicine Today Group offers free online subscriptions to all health and medical practitioners registered with AHPRA. Log in to access. @Monash_SPHPM @AlfredHealth

Does the pneumococcal polysaccharide vaccine prevent heart attacks and strokes? Read our RCT investigating this here. bit.ly/4pCg6ji @Monash_SPHPM @AlfredHealth

Read an overview of our current understanding of the impact of obesity on the development of HFpEF and an outline of the approach to diagnosis and new therapeutic options. bit.ly/47KfK3N @Monash_SPHPM @AlfredHealth

Fantastic research in the Pacific Islands presented in Suva today. Addressing issues faced by a young population at risk of communicable and non-communicable disease, as well as impacts of climate change.

New 2025 heart failure guidelines released by iCARDIO (International CARDIO Alliance to Improve Disease Outcomes). Global representation, considers resource availability, succinct. @Monash_SPHPM @AlfredHealth pubmed.ncbi.nlm.nih.gov/40533340/

Heart failure symptoms can be hard to recognise, so it's vital to know the signs, including breathlessness 🫁, fatigue🥱, swelling🎈& weight gain⚖️. Take control of your heart health. Talk to your GP. Visit hearts4heart.org.au #Hearts4heart #HFAW #HeartFailure #Comorbidities

Over 100 expert group members contributed to the recent release of the #Antibiotic #guidelines. These incredible #experts come from across #Australia to ensure the recommendations are representative of practice nationwide. We acknowledge and thank these contributors, many of whom are leaders in their therapeutic area, for supporting the delivery of this crucial resource. View our wonderful Antibiotic Expert Group members: bit.ly/3TDlZOs

STAREE-HEART is an ancillary study of the STAtins in Reducing Events in the Elderly (STAREE) study, supported the NHMRC. Here's the protocol and baseline description of participants. @Monash_SPHPM @AlfredHealth bit.ly/4l0SJg8

Therapeutic guidelines has just released Antibiotic Guidelines v17, and I was very lucky to be part of the process. Here is a summary of the new changes that will impact our practice in community and hospital care. bit.ly/445CRnl

We're thrilled to announce an unprecedented update to the #Antibiotic guidelines is now available. This extensive multidisciplinary update includes: ✨ 100+ Clinical expert contributors ✨ 200+ Clinical topics ✨ 1400+ Drug recommendations ✨ New aminoglycoside calculators ✨ Images and diagrams ✨ New patient information The first release covers content updates on infections commonly managed in primary care, as well as information on serious infections often managed in hospitals, such as pneumonia and sepsis. During the project, over 100 local clinical contributors joined our expert groups to expand and update the content! 🔗 Explore the update now: bit.ly/4jh1bax Stay tuned for more updates throughout 2025 as we continue to enhance this vital clinical resource. #AntibioticGuidelines #HealthcareUpdate #PatientCare #InfectionControl #AntibioticStewardship #PublicHealth

New #ESCGuidelines on #Afib 2024 The 🆕 AF-CARE pathway 💡Comorbodity and risk factor management 💡Avoid stroke 💡Reduce symptoms by rate and rhythm control 💡Evaluation and dynamic reassessment #ESCCongress @escardio

RCT of AF ablation vs rate control in HFrEF with CMR Ventricular fibrosis at late breakers this Sunday ⁦@drsunnyprabhu⁩ ⁦@drlouisesegan⁩ ⁦@UniMelb⁩ @AlfHeartCentre⁩ #ESC2024

At #ESCCongress in London. New tranche of guidelines including AF with a new approach “AF-CARE”. Looking forward to using the handy patient guide accompanying it. bit.ly/4g91cMX

Quality use of medicines: who owns it now? Catch up on the latest episode of #AustralianPrescriber Podcast to find out about the challenges and opportunities following the closure of NPS MedicineWise. #QUM #QualityUseMedicines #Australia Stream now 👉 buff.ly/3AyxCA9

When cardiovascular medicines should be discontinued @ESC_Journals @escardio academic.oup.com/eurheartj/arti…

One of our incredible editors, Lisa Waddell is at @CRE_RESPOND Forum today giving a talk about how literature informs Therapeutic Guidelines: Antibiotic. We're always working to support improved antimicrobial use. #AMR #AMS #antibiotics

Therapeutic inertia can be addressed by understanding the views of prescribers. Read about general physicians' perceptions of the newest medication for heart failure. @AlfredHealth @Monash_SPHPM doi.org/10.1111/imj.16…

This simple puffer holder has helped our lung function team become greener, cutting the use of inhalers from 5000 per year to just 50. More: tinyurl.com/yckfr636

Who owns #QUM now? The closure of NPS MedicineWise and a shift in #healthpolicy increases the opportunities and risks for quality use of medicines (QUM) in #Australia. An overarching governance network of key QUM stakeholders could have many benefits such as fostering a shared agenda, improving coordination, and aiming for a collective impact approach to deliver public value. Get the latest: bit.ly/4b6M7rd